# The Study of CM310 in Patients With Atopic Dermatitis

> **NCT04893707** · PHASE2 · COMPLETED · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 127 (actual)

## Conditions studied

- Moderate-to-severe Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** CM310

## Key facts

- **NCT ID:** NCT04893707
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-07
- **Primary completion:** 2023-02-03
- **Final completion:** 2023-02-03
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2024-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04893707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04893707, "The Study of CM310 in Patients With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04893707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*